News
2h
InvestorsHub on MSNDynavax shares jump 8% after promising shingles vaccine trial results
Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from ...
Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's blockbuster shot Shingrix, while showing a better safety profile, in an ...
Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...
Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...
Shingles—also known as herpes zoster—is caused by the varicella-zoster virus, the same one that causes chickenpox. If you had that malady as a kid, you’re at risk for a case of shingles ...
Sen. Dianne Feinstein of California, age 89, is home from the hospital recovering from a bout of shingles. Here's what to know about the painful rash caused by a virus.
Shingles will strike 1 in 3 Americans during their lifetimes — most between ages 60 and 70. Folks in their 60s get shingles at roughly twice the rate as folks in their 50s, reports the CDC.
Although shingles vaccination rates have inched upward in recent years, only a third of adults who were 60 or older in 2016 had received the Zostavax vaccine, the CDC says.
The weight of the asphalt shingles stacked on the rooftop was too much, it caused the roof and the walls to collapse, he said. "I couldn't believe it," he said. It is a modest house.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results